2023

McClure, M.E., Gopaluni, S., Wason, J., Henderson, R.B., Van Maurik, A., Savage, C.C.O., ...Lee, J. (2023). A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol. Trials, 24 (1), doi:10.1186/s13063-023-07218-y
Glover, E.K., Smith-Jackson, K., Brocklebank, V., Wilson, V., Walsh, P.R., Montgomery, E.K., ...Kavanagh, D. (2023). Assessing the Impact of Prophylactic Eculizumab on Renal Graft Survival in Atypical Hemolytic Uremic Syndrome. Transplantation, 107 (4), 994-1003. doi:10.1097/TP.0000000000004355
Henderson, S.R., Horsley, H., Frankel, P., Khosravi, M., Goble, T., Carter, S., ...Chu, T.-.Y. (2023). Proteinase 3 promotes formation of multinucleated giant cells and granuloma-like structures in patients with granulomatosis with polyangiitis. Annals of the Rheumatic Diseases, doi:10.1136/ard-2021-221800

2022

Lukhna, K., do Carmo, H.R.P., Castillo, A.R., Davidson, S.M., Geffen, H., Giesz, S., ...Salama, A. (2022). Effect of Remote Ischaemic Conditioning on the Inflammatory Cytokine Cascade of COVID-19 (RIC in COVID-19): a Randomized Controlled Trial. Cardiovascular Drugs and Therapy, doi:10.1007/s10557-022-07411-2
Chu, T.Y., Zheng-Gérard, C., Huang, K.Y., Chang, Y.C., Chen, Y.W., I, K.Y., ...Stacey, M. (2022). GPR97 triggers inflammatory processes in human neutrophils via a macromolecular complex upstream of PAR2 activation. Nature Communications, 13 doi:10.1038/s41467-022-34083-1
Antonelou, M., Evans, R.D.R., Henderson, S.R., Salama, A.D. (2022). Neutrophils are key mediators in crescentic glomerulonephritis and targets for new therapeutic approaches. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 37 (2), 230-238. doi:10.1093/ndt/gfaa206
Ashby, D.R., Caplin, B., Corbett, R.W., Asgari, E., Kumar, N., Sarnowski, A., ...Chen, J. (2022). Outcome and effect of vaccination in SARS-CoV-2 Omicron infection in hemodialysis patients: a cohort study.. Nephrology Dialysis Transplantation, gfac209. doi:10.1093/ndt/gfac209
Ebert, M., Jerke, U., Eulenberg-Gustavus, C., Kling, L., Jenne, D., Kirchner, M., ...Eckardt, K.U. (2022). Protective α1-antitrypsin effects in autoimmune vasculitis are compromised by methionine oxidation. Journal of Clinical Investigation, 132 (23), doi:10.1172/JCI160089
Bell, R.M., Basalay, M., Bøtker, H.E., Beikoghli Kalkhoran, S., Carr, R.D., Cunningham, J., ...Ghosh, A.K. (2022). Remote ischaemic conditioning: defining critical criteria for success-report from the 11th Hatter Cardiovascular Workshop. Basic Research in Cardiology, 117 (1), doi:10.1007/s00395-022-00947-2
Ashby, D.R., Caplin, B., Corbett, R.W., Asgari, E., Kumar, N., Sarnowski, A., ...Chen, J. (2022). Severity of COVID-19 after Vaccination among Hemodialysis Patients: An Observational Cohort Study.. Clin J Am Soc Nephrol, doi:10.2215/CJN.16621221
Hendra, H., Salama, A.D. (2022). Steroids as treatment for glomerulonephritis: time for a rethink. NEPHROLOGY DIALYSIS TRANSPLANTATION, 37 (7), 1212-1217. doi:10.1093/ndt/gfaa267
Mastrotto, F., Pirazzini, M., Negro, S., Salama, A., Martinez-Pomares, L., Mantovani, G. (2022). Sulfation at Glycopolymer Side Chains Switches Activity at the Macrophage Mannose Receptor (CD206) in Vitro and in Vivo. Journal of the American Chemical Society, 144 (50), 23134-23147. doi:10.1021/jacs.2c10757
Aymonnier, K., Amsler, J., Lamprecht, P., Salama, A., Witko-Sarsat, V. (2022). The neutrophil: A key resourceful agent in immune-mediated vasculitis. Immunological Reviews, doi:10.1111/imr.13170

2021

Scott, J., Canepa, C., Buettner, A., Ryan, L., Moloney, B., Cormican, S., ...Little, M.A. (2021). A cohort study to investigate sex-specific differences in ANCA-associated glomerulonephritis outcomes. Scientific Reports, 11 doi:10.1038/s41598-021-92629-7
Greenan-Barrett, J., Doolan, G., Shah, D., Virdee, S., Robinson, G., Choida, V., ...Al-Obaidi, M. (2021). Biomarkers Associated with Organ-Specific Involvement in Juvenile Systemic Lupus Erythematosus. International Journal of Molecular Sciences, doi:10.3390/ijms22147619
Antonelou, M., Abro, A., Heath, R., Iacovou, A., Ashley, C., Caplan, J., ...Salama, A.D. (2021). Comparison of outcomes using the rituximab originator MabThera with the biosimilar Truxima in patients with ANCA-associated vasculitis. Scandinavian Journal of Rheumatology, doi:10.1080/03009742.2021.1926318
Davidson, S.M., Lukhna, K., Gorog, D.A., Salama, A.D., Castillo, A.R., Giesz, S., ...Imamdin, A. (2021). Correction to: RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19. Cardiovascular Drugs and Therapy, doi:10.1007/s10557-021-07223-w
Shipa, M., Embleton-Thirsk, A., Parvaz, M., Santos, L.R., Muller, P., Chowdhury, K., ...Ehrenstein, M.R. (2021). Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus: A Randomized Controlled Trial. Annals of Internal Medicine, doi:10.7326/M21-2078
Neradova, A., Vajgel, G., Hendra, H., Antonelou, M., Kostakis, I.D., Wright, D., ...Salama, A. (2021). Frailty score before admission as risk factor for mortality of renal patients during the first wave of the COVID pandemic in London. Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 38 (3),
Hendra, H., Vajgel, G., Antonelou, M., Neradova, A., Manson, B., Clark, S.G., ...Salama, A.D. (2021). Identifying prognostic risk factors for poor outcome following COVID-19 disease among in-centre haemodialysis patients: role of inflammation and frailty. Journal of Nephrology, doi:10.1007/s40620-020-00960-5
Anandh, U., Gowrishankar, S., Sharma, A., Salama, A., Dasgupta, I. (2021). Kidney transplant dysfunction in a patient with COVID − 19 infection: role of concurrent Sars-Cov 2 nephropathy, chronic rejection and vitamin C-mediated hyperoxalosis: case report. BMC Nephrology, 22 (1), doi:10.1186/s12882-021-02298-x
Carr, E.J., Wu, M., Harvey, R., Wall, E.C., Kelly, G., Hussain, S., ...Gandhi, S. (2021). Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients. LANCET, 398 (10305), 1038-1041. doi:10.1016/S0140-6736(21)01854-7
Muir, L., Jaffer, A., Rees-Spear, C., Gopalan, V., Chang, F., Fernando, R., ...Earl, C. (2021). Neutralizing Antibody Responses After SARS-CoV-2 Infection in End-Stage Kidney Disease and Protection Against Reinfection. Kidney International Reports, doi:10.1016/j.ekir.2021.03.902
King, C., Druce, K.L., Nightingale, P., Kay, E., Basu, N., Salama, A.D., Harper, L. (2021). Predicting relapse in anti-neutrophil cytoplasmic antibody-associated vasculitis: A Systematic review and meta-analysis. Rheumatology Advances in Practice, 5 (3), doi:10.1093/rap/rkab018
Muir, L., Jaffer, A., Rees-Spear, C., Gopalan, V., Chang, F., Vaitkute, G., ...Earl, C. (2021). Profile Of SARS-CoV-2 Antibodies In Patients Awaiting Kidney Transplantation.
Davidson, S.M., Lukhna, K., Gorog, D.A., Salama, A.D., Castillo, A.R., Giesz, S., ...Imamdin, A. (2021). RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19. Cardiovascular Drugs and Therapy, doi:10.1007/s10557-021-07221-y
Rutherford, M.A., Scott, J., Karabayas, M., Antonelou, M., Gopaluni, S., Gray, D., ...McAdoo, S.P. (2021). Risk factors for severe outcomes in patients with systemic vasculitis & COVID-19: a bi-national registry-based cohort study.. Arthritis Rheumatol, doi:10.1002/art.41728
Caplin, B., Ashby, D., McCafferty, K., Hull, R., Asgari, E., Ford, M., ...Srinivasa, V. (2021). Risk of COVID-19 Disease, Dialysis Unit Attributes, and Infection Control Strategy among London In-Center Hemodialysis Patients. Clinical Journal of the American Society of Nephrology, doi:10.2215/CJN.03180321
Gauckler, P., Shin, J.I., Alberici, F., Audard, V., Bruchfeld, A., Busch, M., ...Eller, K. (2021). Rituximab in Membranous Nephropathy. Kidney International Reports, doi:10.1016/j.ekir.2020.12.035
jaffer, A., Muir, L., Gopalan, V., Fernando, R., Chang, F., Vaitkute, A., ...Motallebzadeh, R. (2021). SARS-CoV-2 antibody responses in wait-listed patients for renal transplantation.
Poo, S.X., Pepper, R.J., Onwordi, L., Ghufoor, K., Sandhu, G., Salama, A.D. (2021). Sirolimus use in patients with subglottic stenosis in the context of granulomatosis with polyangiitis (GPA), suspected GPA, and immunoglobulin G4-related disease. Scandinavian Journal of Rheumatology, 1-6. doi:10.1080/03009742.2020.1777324
Giles, I., Salama, A. (2021). The autoimmune rheumatic diseases – an introduction. Medicine, doi:10.1016/j.mpmed.2021.10.001
Hendra, H., Mahalingasivam, V., Salama, A.D., Burns, A. (2021). The Case: Unexplained inflammation after treatment for granulomatosis with polyangiitis. Kidney International, 100 (5), 1147-1148. doi:10.1016/j.kint.2021.04.014
Cherukuri, A., Salama, A.D., Mehta, R., Mohib, K., Zheng, L., Magee, C., ...Tevar, A. (2021). Transitional B cell cytokines predict renal allograft outcomes. Science Translational Medicine, 13 (582), doi:10.1126/scitranslmed.abe4929

2020

Moiseev, S., Tervaert, J.W.C., Arimura, Y., Bogdanos, D.P., Csernok, E., Damoiseaux, J., ...Invernizzi, P. (2020). 2020 international consensus on ANCA testing beyond systemic vasculitis. AUTOIMMUNITY REVIEWS, 19 (9), doi:10.1016/j.autrev.2020.102618
Salama, A.D., Little, M.A. (2020). Coaxing Anti-Inflammatory Granulocytes to Prevent Ischemic Kidney Injury: A Fine Balance. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 31 (4), 668-670. doi:10.1681/ASN.2020020146
Roper, T., Harber, M., Jones, G., Pitceathly, R.D.S., Salama, A.D. (2020). Delayed diagnoses of mitochondrial cytopathies in patients presenting with end stage kidney disease: two case reports.. BMC Nephrol, 21 (1), 361. doi:10.1186/s12882-020-02002-5
Weiner, M., Goh, S.M., Mohammad, A.J., Hrušková, Z., Tanna, A., Sharp, P., ...Chocová, Z. (2020). Effect of Treatment on Damage and Hospitalization in Elderly Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis.. J Rheumatol, doi:10.3899/jrheum.190019
Mccafferty, K., Caplin, B., Knight, S., Hockings, P., Wheeler, D., Fan, S.L., ...Papastefanou, V. (2020). HEROIC: a 5-year observational cohort study aimed at identifying novel factors that drive diabetic kidney disease: rationale and study protocol.. BMJ Open, 10 (9), e033923. doi:10.1136/bmjopen-2019-033923
Salama, A. (2020). IgA Vasculitis and Anti-GBM disease: two ends of a spectrum of immune complex vasculitis. Rheumatology, doi:10.1093/rheumatology/kez540
Evans, R.D.R., Antonelou, M., Sathiananthamoorthy, S., Rega, M., Henderson, S., Ceron-Gutierrez, L., ...Walsh, S.B. (2020). Inherited salt-losing tubulopathies are associated with immunodeficiency due to impaired IL-17 responses. NATURE COMMUNICATIONS, 11 (1), doi:10.1038/s41467-020-18184-3
Moiseev, S., Tervaert, J.W.C., Arimura, Y., Bogdanos, D., Elena, C., Damoiseaux, J., ...Invernizzi, P. (2020). INTERNATIONAL CONSENSUS ON ANCA TESTING AND INTERPRETATION BEYOND SYSTEMIC VASCULITIS.
Law, S., Gillmore, J., Gilbertson, J.A., Bass, P., Salama, A.D. (2020). Karyomegalic interstitial nephritis with a novel FAN1 gene mutation and concurrent ALECT2 amyloidosis. BMC Nephrology, 21 (1), doi:10.1186/s12882-020-01733-9
Salama, A.D., Caplin, B. (2020). Lupus Nephritis and Chronic Kidney Disease.. J Rheumatol, 47 (9), 1303-1304. doi:10.3899/jrheum.200566
Maughan, E.F., Michaels, J., Miller, B., Weir, J., Salama, A., Warner, E., ...Al Yaghchi, C. (2020). Primary Immunoglobulin G4-Related Laryngeal Disease: A Case Series and Review of Literature. Clinical Medicine Insights: Case Reports, 13 doi:10.1177/1179547620960197
Tieu, J., Smith, R., Basu, N., Brogan, P., D'Cruz, D., Dhaun, N., ...Lanyon, P.C. (2020). Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines. Rheumatology (Oxford, England), 59 (4), e24-e32. doi:10.1093/rheumatology/kez640
Tieu, J., Smith, R., Basu, N., Brogan, P., D'Cruz, D., Dhaun, N., ...Lanyon, P.C. (2020). Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines—Executive summary. Rheumatology (Oxford, England), 59 (4), 727-731. doi:10.1093/rheumatology/kez632
Gauckler, P., Shin, J.I., Alberici, F., Audard, V., Bruchfeld, A., Busch, M., ...Eller, K. (2020). Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?. Autoimmunity Reviews, doi:10.1016/j.autrev.2020.102671
Antonelou, M., Michaëlsson, E., Evans, R.D.R., Wang, C.J., Henderson, S.R., Walker, L.S.K., ...RAVE-ITN, I.n.v.e.s.t.i.g.a.t.o.r.s. (2020). Therapeutic Myeloperoxidase Inhibition Attenuates Neutrophil Activation, ANCA-Mediated Endothelial Damage, and Crescentic GN.. J Am Soc Nephrol, doi:10.1681/ASN.2019060618

2019

Pepper, R.J., McAdoo, S.P., Moran, S.M., Kelly, D., Scott, J., Hamour, S., ...Levy, J.B. (2019). A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis (vol 58, pg 260, 2019). RHEUMATOLOGY, 58 (2), 373. doi:10.1093/rheumatology/kez001
Antonelou, M., Ortega, L.P., Harvey, J., Salama, A.D. (2019). Anti-myeloperoxidase antibody positivity in patients without primary systemic vasculitis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 37 (2), S86-S89.
Hruskova, Z., Pippias, M., Stel, V.S., Abad-Diez, J.M., Sanchez, M.B., Caskey, F.J., ...Heaf, J.G. (2019). Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry. AMERICAN JOURNAL OF KIDNEY DISEASES, 73 (2), 184-193. doi:10.1053/j.ajkd.2018.05.016
Salama, A., Pepper, R., Mcadoo, S., Pusey, C. (2019). Comment on: A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis: reply. Rheumatology (Oxford, England), 58 (6), 1119. doi:10.1093/rheumatology/kez038
Pepper, R., Jayne, D., Little, M., Pusey, C., Salama, A.D. (2019). Comment on: A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody–associated vasculitis: reply. Rheumatology, 58 (4), 738-739. doi:10.1093/rheumatology/key388
Evans, R.D.R., Antonelou, M., Henderson, S., Walsh, S.B., Salama, A.D. (2019). Emerging evidence of an effect of salt on innate and adaptive immunity.. Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfy362
Wong, L., Mescia, F., Alberici, F., Ball, M.J., Baslund, B., Brenchley, P., ...Coulson, R.M.R. (2019). GENETIC EVIDENCE OF EOSINOPHIL NUMBER UNDERPINNING PR3-AAV AND PLAUSIBLE HOST GENETIC PREDISPOSITION TO MICROBIAL DRIVERS OF DISEASE.
Wijetilleka, S., Mukhtyar, C., Jayne, D., Ala, A., Bright, P., Chinoy, H., ...Li, C. (2019). Immunoglobulin replacement for secondary immunodeficiency after B-cell targeted therapies in autoimmune rheumatic disease: Systematic literature review. Autoimmunity Reviews, 18 (5), 535-541. doi:10.1016/j.autrev.2019.03.010
Chanouzas, D., McGregor, J.A.G., Nightingale, P., Salama, A.D., Szpirt, W.M., Basu, N., ...Krarup, E. (2019). Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort study. BMC nephrology, 20 (1), 58. doi:10.1186/s12882-019-1226-0
Mohidin, B., Bass, P., Salama, A., Hamour, S. (2019). Malignant renal obstruction without dilatation. Acute Medicine, 18 (2), 121-123.
Jones, R.B., Hiemstra, T.F., Ballarin, J., Blockmans, D.E., Brogan, P., Bruchfeld, A., ...Espigol-Frigolé, G. (2019). Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial.. Ann Rheum Dis, doi:10.1136/annrheumdis-2018-214245
Wijetilleka, S., Jayne, D.R., Mukhtyar, C., Ala, A., Bright, P.D., Chinoy, H., ...Li, C.K. (2019). Recommendations for the management of secondary hypogammaglobulinaemia due to B cell targeted therapies in autoimmune rheumatic diseases. RHEUMATOLOGY, 58 (5), 889-896. doi:10.1093/rheumatology/key394
Salama, A.D. (2019). Relapse in Anti-neutrophil cytoplasm antibody (ANCA) associated vasculitis. Kidney International Reports, doi:10.1016/j.ekir.2019.10.005
Ntatsaki, E., Vassiliou, V.S., Velo-Garcia, A., Salama, A.D., Isenberg, D.A. (2019). Renal transplantation for lupus nephritis: non-adherence and graft survival.. Lupus, 961203319842641. doi:10.1177/0961203319842641
Pepper, R.J., Hutchinson, M., Henderson, S.R., Todd, S.K., Salama, A.D., Hawkins, P.N., Lachmann, H.J. (2019). SERUM S100A8/A9 (CALPROTECTIN) IN FAMILIAL MEDITERRANEAN FEVER DOES NOT CORRELATE WITH DISEASE ACTIVITY.
Antonelou, M., Michaelsson, E., Wang, C., Walker, L., Unwin, R., Salama, A. (2019). THERAPEUTIC MYELOPEROXIDASE INHIBITION ATTENUATES NEUTROPHIL ACTIVATION, ANCA-MEDIATED ENDOTHELIAL DAMAGE AND CRESCENTIC GLOMERULONEPHRITIS.
Everson, L., Bernstein, B.S., Chatterjee, D., Lindsey, B., McCaig, F., Bass, P., Salama, A.D. (2019). ThINK before living donor transplantation. Kidney International, doi:10.1016/j.kint.2018.07.015

2018

Pepper, R.J., McAdoo, S.P., Moran, S.M., Kelly, D., Scott, J., Hamour, S., ...Levy, J.B. (2018). A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody–associated vasculitis. Rheumatology, doi:10.1093/rheumatology/key288
Antonelou, M., Henderson, S.R., Bhangal, G., Oliveira, B., Hamour, S., HARBER, M., Salama, A.D. (2018). Binding Truths: Atypical Anti−Glomerular Basement Membrane Disease Mediated by IgA Anti−Glomerular Basement Membrane Antibodies Targeting the α1 Chain of Type IV Collagen. Kidney International Reports, doi:10.1016/j.ekir.2018.08.005
Evans, R.D.R., Cargill, T., Goodchild, G., Oliveira, B., Rodriguez-Justo, M., Pepper, R., ...Barnes, E. (2018). Clinical Manifestations and Long-term Outcomes of IgG4-Related Kidney and Retroperitoneal Involvement in a United Kingdom IgG4-Related Disease Cohort. Kidney International Reports, doi:10.1016/j.ekir.2018.08.011
Ntatsaki, E., Ali, B., Hamour, S., Isenberg, D., Salama, A.D. (2018). COMPARING ADHERENCE TO TREATMENT IN LUPUS AND VASCULITIS PATIENTS.
Sadeghi-Alavijeh, O., Henderson, S., Bass, P., Cook, T., DeGroot, K., Salama, A.D. (2018). Crescentic glomerulonephritis with anti-GBM antibody but no glomerular deposition. BMC Nephrology,
Oleinika, K., Mauri, C., Salama, A.D. (2018). Effector and regulatory B cells in immune-mediated kidney disease. Nature Reviews Nephrology, doi:10.1038/s41581-018-0074-7
Salama, A.D. (2018). Genetics and Pathogenesis of small vessel vasculitis. Best Practice and Research: Clinical Rheumatology, doi:10.1016/j.berh.2018.10.002
Ntatsaki, E., Velo-Garcia, A., Vassiliou, V., Salama, A., Isenberg, D. (2018). Impact of pre-transplant time on dialysis on survival in patients with lupus nephritis.. Clinical Rheumatology, doi:10.1007/s10067-018-4115-1
McAdoo, S.P., Medjeral-Thomas, N., Gopaluni, S., Tanna, A., Mansfield, N., Galliford, J., ...Jayne, D. (2018). Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis. Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfx378
McAdoo, S.P., Medjeral-Thomas, N., Gopaluni, S., Tanna, A., Mansfield, N., Galliford, J., ...Jayne, D. (2018). Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis (vol 33, pg 899, 2018). NEPHROLOGY DIALYSIS TRANSPLANTATION, 33 (5), 899. doi:10.1093/ndt/gfy075
Novick, T.K., Chen, M., Scott, J., Cortazar, F.B., Ayoub, I., Little, M.A., ...Geetha, D. (2018). Patient Outcomes in Renal-Limited Antineutrophil Cytoplasmic Antibody Vasculitis With Inactive Histology. Kidney International Reports, 3 (3), 671-676. doi:10.1016/j.ekir.2018.01.012
Menez, S., Hruskova, Z., Scott, J., Cormican, S., Chen, M., Salama, A.D., ...Honsova, E. (2018). Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody Glomerulonephritis. AMERICAN JOURNAL OF NEPHROLOGY, 48 (6), 465-471. doi:10.1159/000494840
Giles, I., Salama, A.D. (2018). The autoimmune rheumatic diseases – an introduction. Medicine, 46 (2), 77. doi:10.1016/j.mpmed.2017.11.009
Papakrivopoulou, E., Vasilopoulou, E., Lindenmeyer, M.T., Pacheco, S., Brzóska, H.L., Price, K.L., ...Dean, C.H. (2018). Vangl2, a planar cell polarity molecule, is implicated in irreversible and reversible kidney glomerular injury. Journal of Pathology, doi:10.1002/path.5158

2017

Pepper, R.J., Moran, S., Kelly, D., Gopaluni, P., Jayne, D., Hamour, S., ...Salama, A.D. (2017). A Steroid Free Maintenance Regime is an Effective and Safe Treatment Strategy in ANCA Associated Vasculitis And Glomerulonephritis.
Sadeghi-Alavijeh, O., Henderson, S., Bass, P., de Groot, K., Salama, A.D. (2017). Anti-GBM Antibodies in Crescentic Nephritis Without Kidney Binding.
Rajakaruna, G.K., Alpers, C.E., Hung, G., Mason, R.M., Salama, A.D. (2017). Connective Tissue Growth Factor (Ctgf) Is a Critical Mediator of Cryoglobulinaemic Vasculitis (Cv) and a Novel Target for Therapy.
Henderson, S., Salama, A. (2017). Diagnostic and management challenges in Goodpasture’s (anti-glomerular basement membrane) disease. Nephrology, Dialysis and Transplantation, doi:10.1093/ndt/gfx057
Salama, A.D., Oates, T. (2017). Epigenetic modifications in ANCA Associated Vasculitis: Potential for insights into disease pathogenesis and prediction of outcome?. Journal of the American Society of Nephrology, doi:10.1681/ASN.2016111260
Brocklebank, V., Johnson, S., Sheerin, T.P., Marks, S.D., Gilbert, R.D., Tyerman, K., ...Webb, N. (2017). Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland. KIDNEY INTERNATIONAL, 92 (5), 1261-1271. doi:10.1016/j.kint.2017.04.028
Morris, E.C., Fox, T., Chakraverty, R., Tendeiro, R., Snell, K., Rivat, C., ...Buckland, K. (2017). Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult.. Blood, doi:10.1182/blood-2017-04-777136
Prendecki, M., Tanna, A., Salama, A.D., Tam, F.W.K., Caims, T., Taube, D., ...Pusey, C.D. (2017). Long-term outcome in biopsy-proven acute interstitial nephritis treated with steroids. CKJ: Clinical Kidney Journal, 10 (2), 233-239. doi:10.1093/ckj/sfw116
Casian, A., Jones, R., Cader, R., Salama, A.D., Sangle, S., Jayne, D., D'Cruz, D.P. (2017). New Use for an Old Drug: Hydroxychloroquine for the Treatment of ANCA Associated Vasculitis.
Weiner, M., Goh, S.M., Mohammad, A.J., Hruskova, Z., Tanna, A., Sharp, P., ...Chocova, Z. (2017). ORGAN DAMAGE AND HOSPITALIZATION IN ELDERLY PATIENTS WITH ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)-ASSOCIATED VASCULITIS.
Henderson, S.R., Horsley, H., Todd, S.K., Salama, A.D. (2017). PROTEINASE-3 (PR3) AUTO-ANTIGEN DRIVES GIANT CELL AND GRANULOMA FORMATION IN ANCA-ASSOCIATED VASCULITIS (AAV).
Cherukuri, A., Salama, A.D., Carter, C.R., Landsittel, D., Arumugakani, G., Clark, B., ...Baker, R.J. (2017). Reduced human transitional B cell T1/T2 ratio is associated with subsequent deterioration in renal allograft function. KIDNEY INTERNATIONAL, 91 (1), 183-195. doi:10.1016/j.kint.2016.08.028
Oates, T., Florez-Barros, F., Zhao, M., Rutgers, B., Stegeman, C., Heeringa, P., ...Hruskova, Z. (2017). Restablishment of Immune Tolerance in ANCA-Associated Vasculitis: Defining a cohort with sustained ANCA negativity and drug free clinical remission.
Bajema, I.M., Bruijn, J.A., Casian, A., Cid, M.C., Csernok, E., van Daalen, E., ...Luqmani, R.A. (2017). The European Vasculitis Society 2016 Meeting Report. Kidney International Reports, 2 (6), 1018-1031. doi:10.1016/j.ekir.2017.09.008

2016

Ntatsaki, E., Garcia, A.V., Salama, A.D., Isenberg, D.A. (2016). Adherence to Treatment and Renal Transplantation Graft Failure in Lupus Nephritis.
Draibe, J.B., Fulladosa, X., Cruzado, J.M., Torras, J., Salama, A.D. (2016). Current and novel biomarkers in anti-neutrophil cytoplasm-associated vasculitis. CKJ: Clinical Kidney Journal, 9 (4), 547-551. doi:10.1093/ckj/sfw056
Papakrivopoulou, E., Shendi, A.M., Salama, A.D., Khosravi, M., Connolly, J.O., Trompeter, R. (2016). Effective treatment with rituximab for the maintenance of remission in frequently relapsing minimal change disease. NEPHROLOGY, 21 (10), 893-900. doi:10.1111/nep.12744
Salama, A.D., Pusey, C.D. (2016). Microscopic polyangiitis. In Interstitial Pulmonary and Bronchiolar Disorders. (pp. 657-670). .
Henderson, S.R., Shah, A., Copley, S.J., Cook, H.T., Pusey, C.D., Salama, A.D., Ind, P.W. (2016). Occam's razor or Hickam's dictum? Allergic bronchopulmonary aspergillosis and eosinophilic granulomatosis with polyangiitis. Thorax, 71 (2), 193-195. doi:10.1136/thoraxjnl-2015-207280
Rezk, T., Penton, J., Stevenson, A., Owen-Casey, M., Little, M., Cunningham, J., Salama, A.D. (2016). Pauci Immune crescentic glomerulonephritis in a patient with T-cell lymphoma and argyria. BMC NEPHROLOGY, 17 doi:10.1186/s12882-016-0259-x
Ntatsaki, E., Velo Garcia, A., Gracia Tello, B.D.C., Salama, A.D., Isenberg, D.A. (2016). Predictors of Survival in Renal Transplantation for Lupus Nephritis-40 Patients in 40 Years.
Oomatia, A., Moran, S.M., Kennedy, C., Sequeira, R., Hamour, S., Burns, A., ...Salama, A.D. (2016). Prolonged Duration of Renal Recovery Following ANCA-Associated Glomerulonephritis. AMERICAN JOURNAL OF NEPHROLOGY, 43 (2), 112-119. doi:10.1159/000444925
Salama, A.D., Pepper, R.J., draibe, J.B., Caplin, B., Fervenza, F.C., Hoffman, G., ...Seo, P. (2016). The association of serum calprotectin (S100A8/S100A9) levels with disease relapses in PR3-ANCA-associated vasculitis. Arthritis and Rheumatology,
Draibe, J., Pepper, R.J., Salama, A.D. (2016). Treatment with Quinoline-3-carboxamide does not successfully prevent immune-mediated glomerulonephritis in mice. Nefrologia, 36 (6), 687-693. doi:10.1016/j.nefro.2016.03.012

2015

Draibe, J., Salama, A.D. (2015). Association of ANCA associated vasculitis and rheumatoid arthritis: a lesser recognized overlap syndrome. SpringerPlus, 4 doi:10.1186/s40064-015-0835-8
Turner-Stokes, T., Sandhu, E., Pepper, R.J., Salama, A.D., Burns, A., Little, M.A. (2015). Comment on: Induction treatment of ANCA-associated vasculitis with a single dose of rituximab: reply. RHEUMATOLOGY, 54 (2), 373-374. doi:10.1093/rheumatology/keu440
Geetha, D., Kallenberg, C., Stone, J.H., Salama, A.D., Appel, G.B., Duna, G., ...Jayne, D. (2015). Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab. JOURNAL OF NEPHROLOGY, 28 (1), 17-27. doi:10.1007/s40620-014-0135-3
Hamour, S., Gan, P.Y., Pepper, R., Florez Barros, F., Wang, H.H., O'Sullivan, K., ...Holdsworth, S. (2015). Local IL-17 Production Exerts a Protective Role in Murine Experimental Glomerulonephritis. PLoS One, 10 (8), doi:10.1371/journal.pone.0136238
Tanna, A., Guarino, L., Tam, F.W.K., Rodriquez-Cubillo, B., Levy, J.B., Cairns, T.D., ...Salama, A.D. (2015). Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors. NEPHROLOGY DIALYSIS TRANSPLANTATION, 30 (7), 1185-1192. doi:10.1093/ndt/gfu237
Greenhall, G., Vancheeswaran, R., Burns, A., Bass, P., Salama, A.D. (2015). Macrolide therapy and alveolar hemorrhage secondary to granulomatosis with polyangiitis. Journal of Vasculitis, 1 (1), doi:10.4172/jov.1000101
Weiner, M., Goh, S.M., Mohammad, A.J., Hruskova, Z., Tanna, A., Bruchfeld, A., ...Eriksson, P. (2015). Outcome and Treatment of Elderly Patients with ANCA-Associated Vasculitis. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 10 (7), 1128-1135. doi:10.2215/CJN.00480115
Croft, A.P., Smith, S.W., Carr, S., Youssouf, S., Salama, A.D., Burns, A., ...Venning, M. (2015). Successful outcome of pregnancy in patients with anti-neutrophil cytoplasm antibody-associated small vessel vasculitis. KIDNEY INTERNATIONAL, 87 (4), 807-811. doi:10.1038/ki.2014.329
Salama, A.D., Little, M.A. (2015). The Janus Faces of IL-6 in GN. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 26 (7), 1480-1482. doi:10.1681/ASN.2014111141
Greenhall, G.H.B., Salama, A.D. (2015). What is new in the management of rapidly progressive glomerulonephritis?. Clinical Kidney Journal, 8 (2), 143-150. doi:10.1093/ckj/sfv008

2014

Evans, R., Gueret-Wardle, A., Edwards, S., Salama, A. (2014). ANCA-associated vasculitis and pauci-immune glomerulonephritis in HIV disease. BMJ Case Reports, doi:10.1136/bcr-2013-202423
Salama, A.D., Rees, A.J. (2014). Autoantibodies in anti-neutrophil cytoplasm antibody-associated vasculitis. NEPHROLOGY DIALYSIS TRANSPLANTATION, 29 (6), 1105-1107. doi:10.1093/ndt/gft526
Salama, A.D., Little, M.A. (2014). Experimental autoimmune vasculitis: Insights into human vasculitis using animal models. In The Vasculitides. (pp. 85-94). .
Salama, A.D. (2014). Goodpasture’s or anti-glomerular basement membrane (GBM) disease. In Practical Nephrology. (pp. 227-233). .
Lavainne, F., Meffray, E., Pepper, R.J., Néel, M., Delcroix, C., Salama, A.D., Fakhouri, F. (2014). Heparin use during dialysis sessions induces an increase in the antiangiogenic factor soluble Flt1. NEPHROLOGY DIALYSIS TRANSPLANTATION, 29 (6), 1225-1231. doi:10.1093/ndt/gft517
Cherukuri, A., Rothstein, D.M., Clark, B., Carter, C.R., Davison, A., Hernandez-Fuentes, M., ...Baker, R.J. (2014). Immunologic Human Renal Allograft Injury Associates with an Altered IL-10/TNF-alpha Expression Ratio in Regulatory B Cells. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 25 (7), 1575-1585. doi:10.1681/ASN.2013080837
Turner-Stokes, T., Sandhu, E., Pepper, R.J., Stolagiewicz, N.E., Ashley, C., Dinneen, D., ...Little, M.A. (2014). Induction treatment of ANCA-associated vasculitis with a single dose of rituximab.. Rheumatology (Oxford, England), 53 (8), 1395-1403.
Turner-Stokes, T., Sandhu, E., Pepper, R.J., Stolagiewicz, N.E., Ashley, C., Dinneen, D., ...Little, M.A. (2014). Induction treatment of ANCA-associated vasculitis with a single dose of rituximab.. RHEUMATOLOGY, 53 (8), 1395-1403. doi:10.1093/rheumatology/ket489
Pepper, R.J., Salama, A.D. (2014). Practical immunosuppression guidelines for patients with glomerulonephritis. In Practical Nephrology. (pp. 249-256). .
Todd, S.K., Pepper, R.J., Draibe, J., Tanna, A., Pusey, C.D., Mauri, C., Salama, A.D. (2014). Regulatory B cells are numerically but not functionally deficient in anti-neutrophil cytoplasm antibody-associated vasculitis. Rheumatology, 53 (9), 1693-1703. doi:10.1093/rheumatology/keu136
Draibe, J.B., Pepper, R.J., Merkel, P.A., Salama, A.D. (2014). Serum Calprotectin and Disease Relapse in ANCA-Associated Vasculitis.. ARTHRITIS & RHEUMATOLOGY, 66 S818-S819.
Sznajd, J., Salama, A.D., Jayne, D., Chaudhry, A., Robson, M., Rosa, J., ...Little, M.A. (2014). UK & IRELAND VASCULITIS REGISTRY (UKIVAS): CROSS-SECTIONAL DATA ON THE FIRST 556 PATIENTS.
Sznajd, J., Salama, A.D., Jayne, D., Chaudhry, A., Robson, M., Rosa, J., ...Lanyon, P. (2014). United Kingdom & Ireland Vasculitis Registry - Cross-Sectional Data on the First 1085 Patients. ARTHRITIS & RHEUMATOLOGY, 66 S773.
Evans, R., Salama, A.D. (2014). Update on Rituximab: An Established Treatment for All Immune-Mediated Kidney Diseases?. NEPHRON CLINICAL PRACTICE, 126 (3), 97-109. doi:10.1159/000358887

2013

Salama, A.D. (2013). Anti- glomerular basement membrane disease. In Practical Nephrology. Springer.
Salama, A.D. (2013). Anti-glomerular basement membrane disease. In Lin, J., Fervenza, F. (Eds.), Core concepts in Parenchymal Kidney Disease. Springer.
Todd, S.K. (2013). B regulatory cells are numerically but not functionally impaired in AAV.
Pepper, R.J., Hamour, S., Chavele, K.M., Rasmussen, N., Flint, S., Lyons, P.A., ...Salama, A.D. (2013). Calprotectin has a pathogenic pro-inflammatory role in anti-neutrophil cytoplasmic antibody associated vasculitis and glomerulonephritis.
Pepper, R.J., Chanouzas, D., Tarzi, R., Little, M.A., Casian, A., Walsh, M., ...Salama, A.D. (2013). European Vasculitis Study (EUVAS) investigators: Intravenous cyclophosphamide and plasmapheresis in dialysis-dependent ANCA-associated vasculitis (vol 8, pg 219, 2013). CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 8 (4), 701.
Pepper, R.J., Chanouzas, D., Tarzi, R., Little, M., Caisian, A., Walsh, M., ...EUVAS, I.n.v.e.s.t.i.g.a.t.o.r.s. (2013). Intravenous Cyclophosphamide and Plasmapheresis in Dialysis-Dependent ANCA-Associated Vasculitis. Clinical Journal of the American Society of Nephrology, 8
Pepper, R.J., Salama, A.D. (2013). Practical immunosuppression. In Practical Nephrology. Springer.
derrett-smith, E., Nihtyanova, S., harvey, J., Salama, A.D., denton, C. (2013). Revisiting ANCA-associated vasculitis in systemic sclerosis: clinical, serological and immunogenetic factors. Rheumatology,
Mcdaid, J.P., Tanna, A., Bhangal, G., Little, M.A., Behmoaras, J., Cook, H.T., ...Pusey, C.D. (2013). The role of quantitative trait loci (QTL) in the pathogenesis of experimental autoimmune vasculitis (EAV). PRESSE MEDICALE, 42 (4), 688. doi:10.1016/j.lpm.2013.02.088

2012

Caplin, B.D., Wang, Z., Slaviero, A., Tomlinson, J., Dowsett, L., Delahaye, M., ...Leiper, J. (2012). Alanine-glyoxylate aminotransferase-2 metabolises endogenous methylarginines, regulates nitric oxide and controls blood pressure. Arterioscler Thromb Vasc Biol, Epub ahead of print doi:10.1161/ATVBAHA.112.254078
Caplin, B., Wang, Z., Slaviero, A., Tomlinson, J., Dowsett, L., Delahey, M., ...Leiper, J. (2012). Alanine-Glyoxylate Aminotransferase-2 Metabolizes Endogenous Methylarginines, Regulates NO, and Controls Blood Pressure.. Arterioscler Thromb Vasc Biol, 2012 Sep 27. [Epub ahead of print]
Cherukuri, A., Salama, A.D., Carter, C., Smalle, N., McCurtin, R., Hewitt, E.W., ...Baker, R.J. (2012). An analysis of lymphocyte phenotype after steroid avoidance with either alemtuzumab or basiliximab induction in renal transplantation.. AMERICAN JOURNAL OF TRANSPLANTATION, 12 (4), 919-931. doi:10.1111/j.1600-6143.2011.03891.x
Salama, A.D., Little, M.A. (2012). Animal models of antineutrophil cytoplasm antibody-associated vasculitis.. CURRENT OPINION IN RHEUMATOLOGY, 24 (1), 1-7. doi:10.1097/BOR.0b013e32834d2d52
Hong, Y., Eleftheriou, D., Hussain, A.A.K., Price-Kuehne, F.E., Savage, C.O., Jayne, D., ...Brogan, P.A. (2012). Anti-neutrophil cytoplasmic antibodies stimulate release of neutrophil microparticles.. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 23 (1), 49-62. doi:10.1681/ASN.2011030298
Pepper, R.J., Salama, A.D. (2012). Classifying and predicting outcomes in ANCA-associated glomerulonephritis.. NEPHROLOGY DIALYSIS TRANSPLANTATION, 27 (6), 2135-2137. doi:10.1093/ndt/gfs062
Le Roux, S., Pepper, R.J., Dufay, A., Néel, M., Meffray, E., Lamandé, N., ...Hourmant, M. (2012). Elevated soluble Flt1 inhibits endothelial repair in PR3-ANCA-associated vasculitis.. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 23 (1), 155-164. doi:10.1681/ASN.2010080858
Tanna, A., Salama, A.D., Brookes, P., Pusey, C.D. (2012). Familial granulomatosis with polyangiitis: three cases of this rare disorder in one Indoasian family carrying an identical HLA DPB1 allele. BMJ case reports, 2012 doi:10.1136/bcr.01.2012.5502
Reynolds, J., Tadros, S., Smith, J., Cook, P.R., Bhangal, G., Salama, A.D., ...Pusey, C.D. (2012). Genetic susceptibility to experimental autoimmune glomerulonephritis in congenic rats.
Reynolds, J., Cook, P.R., Behmoaras, J., Smith, J., Bhangal, G., Tadros, S., ...Aitman, T.J. (2012). Genetic susceptibility to experimental autoimmune glomerulonephritis in the Wistar Kyoto rat.. Am J Pathol, 180 (5), 1843-1851.
Lyons, P.A., Rayner, T.F., Trivedi, S., Holle, J.U., Watts, R.A., Jayne, D.R.W., ...Chaudhry, A.N. (2012). Genetically distinct subsets within ANCA-associated vasculitis.. NEW ENGLAND JOURNAL OF MEDICINE, 367 (3), 214-223. doi:10.1056/NEJMoa1108735
Virk, J.S., Stamatoglou, C., Kwame, I., Salama, A., Sandison, A., Sandhu, G. (2012). IgG4-sclerosing pseudotumor of the trachea: A case report and review of the literature. Archives of Otolaryngology - Head and Neck Surgery, 138 (9), 864-866. doi:10.1001/archoto.2012.1821
Pepper, R.J., Hamour, S., Chavele, K.M., Rasmussen, N., Flint, S., Lyons, P.A., ...Salama, A.D. (2012). Leukocyte and serum calprotectin (S100A8/S100A9) expression reflect disease activity in ANCA associated vasculitis and glomerulonephritis. Kidney International, In Press
McAdoo, S.P., Hall, A., Levy, J., Salama, A.D., Pusey, C.D. (2012). Proteinase-3 antineutrophil cytoplasm antibody positivity in patients without primary systemic vasculitis.. J Clin Rheumatol, 18 336-340.
Virk, J.S., Stamatoglou, C., Kwame, I., Salama, A.D., Sandison, A., Sandhu, G. (2012). Pseudotumor of the Trachea: A Case Report and Review of the Literature.. Arch Otolaryngol Head Neck Surg., 138 864-868.
Guerry, M.-.J.C.J., Brogan, P., Bruce, I.N., D'Cruz, D.P., Harper, L., Luqmani, R., ...Savage, C.O.S. (2012). Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.. RHEUMATOLOGY, 51 (4), 634-643. doi:10.1093/rheumatology/ker150
Reynolds, J., Sando, G.S., Marsh, O.B., Salama, A.D., Evans, D.J., Cook, H.T., Pusey, C.D. (2012). Stimulation of the PD-1/PDL-1 T-cell co-inhibitory pathway is effective in treatment of experimental autoimmune glomerulonephritis.. NEPHROLOGY DIALYSIS TRANSPLANTATION, 27 (4), 1343-1350. doi:10.1093/ndt/gfr529

2011

Hamour, S.M., Salama, A.D. (2011). ANCA comes of age-but with caveats.. KIDNEY INTERNATIONAL, 79 (7), 699-701. doi:10.1038/ki.2010.558
Arulkumaran, N., West, S.C., Ind, P.W., Gaskin, G., Tarzi, R., Salama, A.D., Pusey, C.D. (2011). ANCA-AAV and PH.
Morris, H., Morgan, M.D., Wood, A.M., Smith, S.W., Ekeowa, U.I., Herrmann, K., ...Perez, J. (2011). ANCA-associated vasculitis is linked to carriage of the Z allele of α₁ antitrypsin and its polymers.. ANNALS OF THE RHEUMATIC DISEASES, 70 (10), 1851-1856. doi:10.1136/ard.2011.153569
Holden, N.J., Williams, J.M., Morgan, M.D., Challa, A., Gordon, J., Pepper, R.J., ...Savage, C.O.S. (2011). ANCA-stimulated neutrophils release BLyS and promote B cell survival: a clinically relevant cellular process.. ANNALS OF THE RHEUMATIC DISEASES, 70 (12), 2229-2233. doi:10.1136/ard.2011.153890
Salama, A.D. (2011). B cells in the induction of human autoimmune vasculitis.
McAdoo, S.P., Densem, C., Salama, A., Pusey, C.D. (2011). Bacterial endocarditis associated with proteinase 3 anti-neutrophil cytoplasm antibody. NDT Plus, 4 (3), 208-210. doi:10.1093/ndtplus/sfr030
Salama, A.D., Cook, H.T. (2011). Brenner and Rector's the Kidney The Kidney Biopsy. In Taal, M.W., Chertow, G.M., Marsden, P.A., Skorecki, K., Yu, A.S.L. (Eds.), Brenner and Rector's the Kidney. W B Saunders Co.
Pepper, R.J., Tarzi, R., Wang, H.-.H., Pusey, C.D., Cook, H.T., Salama, A.D. (2011). Critical role for calprotectin in ANCA-AAV and GN.
Arulkumaran, N., Periselneris, N., Gaskin, G., Strickland, N., Ind, P.W., Pusey, C.D., Salama, A.D. (2011). Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study.. RHEUMATOLOGY, 50 (11), 2035-2043. doi:10.1093/rheumatology/ker236
Arulkumaran, N., Jawad, S., Smith, S.W., Harper, L., Brogan, P., Pusey, C.D., Salama, A.D. (2011). Long- term outcome of paediatric patients with ANCA vasculitis.. Pediatric Rheumatology, 9 ?. doi:10.1186/1546-0096-9-12
Wang, H.-.H., Salama, A.D., Hamour, S., Pepper, R., Little, M. (2011). MANNOSE RECEPTOR DEFICIENCY PROTECTS MICE FROM ISCHEMIC-REPERFUSION INJURY AND NEPHROTOXIC NEPHRITIS.
Arulkumaran, N., Periselneris, N., Gaskin, G., Strickland, N., Ind, P.W., Pusey, C.D., Salama, A.D. (2011). MPO-ANCA-AAV with pulmonary fibrosis.
Salama, A.D., Little, M. (2011). Oxford textbook of rheumatology Kidney involvement in rheumatologic diseases. In Isenberg, D.A., Isenberg, D. (Eds.), Oxford textbook of rheumatology. Oxford University Press, USA.
Mansfield, N., Hamour, S., Habib, A.-.M., Tarzi, R., Levy, J., Griffith, M., ...Salama, A.D. (2011). Prolonged disease-free remission following rituximab and low-dose cyclophosphamide therapy for renal ANCA-associated vasculitis.. NEPHROLOGY DIALYSIS TRANSPLANTATION, 26 (10), 3280-3286. doi:10.1093/ndt/gfr127
Salama, A.D. (2011). Renal biopsy. Medicine, 39 (6), 339-342. doi:10.1016/j.mpmed.2011.03.006
Pepper, R.J., Chanouzas, D., Tarzi, R., Harper, L., Pusey, C.D., Salama, A.D. (2011). Renal outcomes in patients presenting with dialysis-dependent ANCA-AAV treated with pulsed intravenous CyP.
Joshi, L., Lightman, S.L., Salama, A.D., Shirodkar, A.L., Pusey, C.D., Taylor, S.R.J. (2011). Rituximab in refractory ophthalmic Wegener's granulomatosis: PR3 titers may predict relapse, but repeat treatment can be effective.. OPHTHALMOLOGY, 118 (12), 2498-2503. doi:10.1016/j.ophtha.2011.06.009
Peto, P., Salama, A.D. (2011). Update on antiglomerular basement membrane disease.. CURRENT OPINION IN RHEUMATOLOGY, 23 (1), 32-37. doi:10.1097/BOR.0b013e328341009f

2010

Salama, A.D., Cook, H.T. (2010). Comment on "Non-hepatitis virus-associated mixed essential cryoglobulinemia'' Reply. KIDNEY INTERNATIONAL, 78 (1), 114. doi:10.1038/ki.2010.127
Hamish, M., Geroulakos, G., Hughes, D.A., Moser, S., Shepherd, A., Salama, A.D. (2010). Delayed hepato-spleno-renal bypass for renal salvage following malposition of an infrarenal aortic stent-graft.. JOURNAL OF ENDOVASCULAR THERAPY, 17 (3), 326-331. doi:10.1583/09-3011.1
Basu, N., Watts, R., Bajema, I., Baslund, B., Bley, T., Boers, M., ...Cohen-Tervaert, J.W. (2010). EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis.. ANNALS OF THE RHEUMATIC DISEASES, 69 (10), 1744-1750. doi:10.1136/ard.2009.119032
Chrysochou, C., Power, A., Shurrab, A.E., Husain, S., Moser, S., Lay, J., ...Kalra, P.A. (2010). Low risk for nephrogenic systemic fibrosis in nondialysis patients who have chronic kidney disease and are investigated with gadolinium-enhanced magnetic resonance imaging.. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 5 (3), 484-489. doi:10.2215/CJN.06580909
Salama, A.D. (2010). Management of acute kidney problems: Indications for renal biopsy in acute renal disease. In Management of Acute Kidney Problems. (pp. 117-122). .
Hamour, S., Salama, A.D., Pusey, C.D. (2010). Management of ANCA-associated vasculitis: Current trends and future prospects.. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 6 253-264.
Chavele, K.-.M., Martinez-Pomares, L., Domin, J., Pemberton, S., Haslam, S.M., Dell, A., ...Salama, A.D. (2010). Mannose receptor interacts with Fc receptors and is critical for the development of crescentic glomerulonephritis in mice.. JOURNAL OF CLINICAL INVESTIGATION, 120 (5), 1469-1478. doi:10.1172/JCI41560
Nogueira, E.L., Ind, P.W., Friedland, J.S., Salama, A.D. (2010). Mucormycosis may mimic disease relapse in Wegener's granulomatosis.. JOURNAL OF RHEUMATOLOGY, 37 (6), 1364-1366. doi:10.3899/jrheum.091423
Annear, N.M.P., Cook, H.T., Atkins, M., Pusey, C.D., Salama, A.D. (2010). Non-hepatitis virus associated mixed essential cryoglobulinemia.. KIDNEY INTERNATIONAL, 77 (2), 161-164. doi:10.1038/ki.2009.416
Chavele, K.-.M., Shukla, D., Keteepe-Arachi, T., Seidel, J.A., Fuchs, D., Pusey, C.D., Salama, A.D. (2010). Regulation of myeloperoxidase-specific T cell responses during disease remission in antineutrophil cytoplasmic antibody-associated vasculitis: the role of Treg cells and tryptophan degradation.. ARTHRITIS AND RHEUMATISM, 62 (5), 1539-1548. doi:10.1002/art.27403
Nogueira, E., Hamour, S., Sawant, D., Henderson, S., Mansfield, N., Chavele, K.-.M., ...Salama, A.D. (2010). Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis. NEPHROLOGY DIALYSIS TRANSPLANTATION, 25 (7), 2209-2217. doi:10.1093/ndt/gfp783
Salama, A.D., Hernandes-Fuentes, M. (2010). Transplantation Immunology. In Hornick, P. (Ed.), Transplantation Immunology. Humana Pr Inc.

2009

Hamour, S., Salama, A.D. (2009). 17 and 23: prime numbers that matter.. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 20 (5), 925-927. doi:10.1681/ASN.2009030291
Salama, A., Negeed, E.R., Djamaluddin, I., Esaki, T., Mitani, Y., Ikemi, H. (2009). A GIS-based, hypothetical model of groundwater seepage into a former mining open pit: 1. discrete fractures scenario.
Jones, R.B., Ferraro, A.J., Chaudhry, A.N., Brogan, P., Salama, A.D., Smith, K.G., ...Jayne, D.R. (2009). A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum, 60 (7), 2156-2168. doi:10.1002/art.24637
Jones, R.B., Ferraro, A.J., Chaudhry, A.N., Brogan, P., Salama, A.D., Smith, K.G.C., ...Jayne, D.R.W. (2009). A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis.. ARTHRITIS AND RHEUMATISM, 60 (7), 2156-2168. doi:10.1002/art.24637
Sangha, G., Al-Ani, B., Al-Nuaimi, H., Mukherjee, S., Salama, A., Pusey, C., Little, M. (2009). Absence of myeloperoxidase renal deposition in rat experimental autoimmune vasculitis.
Ishihara, D., Onaka, T., Kataza, H., Fujiwara, H., Takita, S., Alfageme, C., ...Hasegawa, S. (2009). AKARI Mid-Infrared All-sky Survey.
Lachmann, N., Lehmkuhl, H.B., Salama, A., Schoenemann, C. (2009). Chronic cardiac graft rejection due to HLA and MICA antibodies.
Chavele, K.-.M., Martinez-Pomares, L., Gordon, S., Cook, T., Pusey, C., Salama, A. (2009). Circulating mannose receptor is elevated in acute ANCA-associated vasculitis and contributes in the development of experimental glomerulonephritis.
Salama, A.D. (2009). Crescentic Glomerulonephritis. In Barratt, J., Topham, P., Harris, K. (Eds.), Oxford Desk Reference: Nephrology. Oxford University Press, USA.
Kamesh, L., Heward, J.M., Williams, J.M., Gough, S.C.L., Chavele, K.-.M., Salama, A., ...Harper, L. (2009). CT60 and +49 polymorphisms of CTLA 4 are associated with ANCA-positive small vessel vasculitis.. RHEUMATOLOGY, 48 (12), 1502-1505. doi:10.1093/rheumatology/kep280
Mansfield, N., Hamour, S., Nogueira, E., Habib, A.-.M., Pusey, C., Cairns, T., ...Salama, A.D. (2009). CycLowVas: a rituximab (RTX)-based cyclophosphamide (CYP)-sparing regime.
Henderson, S.R., Copley, S.J., Ind, P.W., Salama, A.D. (2009). Effective treatment of granulomatous lesions in Wegener's granulomatosis with rituximab.
Little, M.A., Smyth, L., Salama, A.D., Mukherjee, S., Smith, J., Haskard, D., ...Pusey, C.D. (2009). Experimental autoimmune vasculitis: an animal model of anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis.. AMERICAN JOURNAL OF PATHOLOGY, 174 (4), 1212-1220. doi:10.2353/ajpath.2009.080458
Salama, A.D., Pusey, C.D. (2009). Goodpasture’s Syndrome and Other Anti–Glomerular Basement Membrane Disease. In Primer on Kidney Diseases. (pp. 186-190). .
Salama, A.D., Pusey, C.D. (2009). Goodpasture's syndrome and other Anti-glomerular basement mebrane disease. In Greenberg, A., Cheung, A.K. (Eds.), Primer on kidney diseases. W B Saunders Co.
Bussel, J., Saleh, M., Salama, A., Grotzinger, K.M., Duh, M., Signorovitch, J., ...Aivado, M. (2009). IMPROVEMENT IN FATIGUE AND HEALTH-RELATED QUALITY OF LIFE WITH LONG-TERM ELTROMBOPAG TREATMENT IN ADULTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA: THE EXTEND STUDY.
Salama, A.D. (2009). Management of Acute Kidney Problems. In Jörres, A. (Ed.), Management of Acute Kidney Problems. Springer Verlag.
Kai, A., Espinel-Costoso, L., Trivedi, S., Casal, A., Morgan, M., Levy, J., ...Salama, A.D. (2009). Outcomes of a UK cohort of AAV patients treated with TNF blockade.
Joshi, L., Hamour, S., Salama, A.D., Pusey, C.D., Lightman, S., Taylor, S.R. (2009). Renal & ocular targets for therapy in Wegener's granulomatosis. Inflamm.Allergy Drug Targets., 8 (1), 70-79.
Joshi, L., Hamour, S., Salama, A.D., Pusey, C.D., Lightman, S., Taylor, S.R.J. (2009). Renal & ocular targets for therapy in Wegener's granulomatosis.. Inflammation & allergy drug targets, 8 (1), 70-79. doi:10.2174/187152809787582552
Little, M.A., Hassan, B., Jacques, S., Game, D., Salisbury, E., Courtney, A.E., ...Harper, L. (2009). Renal transplantation in systemic vasculitis: when is it safe?. NEPHROLOGY DIALYSIS TRANSPLANTATION, 24 (10), 3219-3225. doi:10.1093/ndt/gfp347
Taylor, S.R., Salama, A.D., Joshi, L., Pusey, C.D., Lightman, S.L. (2009). Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis. Arthritis Rheum., 60 (5), 1540-1547.
Nogueira, E., Hamour, S., Sawant, D., Henderson, S., Mansfield, N., Chavele, K.-.M., ...Salama, A.D. (2009). Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis.. APMIS, 117 128-129.
Salama, A.D., Pusey, C.D. (2009). Shining a LAMP on pauci-immune focal segmental glomerulonephritis.. KIDNEY INTERNATIONAL, 76 (1), 15-17. doi:10.1038/ki.2009.123
Yamamura, I., Makiuti, S., Ikeda, N., Fukuda, Y., Yamauchi, C., Hasegawa, S., ...Takagi, T. (2009). The First release of the AKARI-FIS Bright Source Catalogue.
Salama, A.D. (2009). Tolerance: A Review of its Mechanisms in the Transplant Setting. In Pediatric Solid Organ Transplantation. (pp. 56-65). .
Peters, J.E., Salama, A.D., Ind, P.W. (2009). Wegener's granulomatosis presenting as acute systemic vasculitis following 20 years of limited tracheobronchial disease.. JOURNAL OF LARYNGOLOGY AND OTOLOGY, 123 (12), 1375-1377. doi:10.1017/S002221510900454X

2008

Salama, A.D., Cook, H.T., Pusey, C.D., Pepper, R.J. (2008). A case of treated ANCA-associated vasculitis with recurrent renal failure.. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 3 (2), 637-645. doi:10.2215/CJN.05071107
Salama, A.D. (2008). Critical care nephrology. In Ronco, C., Bellomo, R., Kellum, J.A. (Eds.), Critical care nephrology. W B Saunders Co.
Lachmann, N., Terasaki, P.I., Budde, K., Liefeld, L., Kahl, A., Reinke, P., ...Schoenemann, C. (2008). Impact of anti-HLA and donor-specific antibodies on renal graft survival: single center study with 5.5-year follow-up.
Saw, V.P.J., Cornelius, N., Salama, A.D., Pusey, C., Lightman, S.L. (2008). Infliximab therapy for aggressive mooren ulceration.. ARCHIVES OF OPHTHALMOLOGY, 126 (5), 734. doi:10.1001/archopht.126.5.734
Salama, A.D., Pusey, C.D. (2008). Interstitial pulmonary and bronchiolar disorders. In Lynch, J.P. (Ed.), Interstitial pulmonary and bronchiolar disorders. Informa HealthCare.
Behmoaras, J., Bhangal, G., Smith, J., McDonald, K., Mutch, B., Lai, P.C., ...Foxwell, B.M. (2008). Jund is a determinant of macrophage activation and is associated with glomerulonephritis susceptibility.. NATURE GENETICS, 40 (5), 553-559. doi:10.1038/ng.137
Salama, A., Robak, T., Kovaleva, L., Vyhovska, Y., Davies, S.V., Mazzucconi, M.G., Zenker, O. (2008). RAPID INCREASE OF PLATELET COUNT WITH IGPRO10 IN CHRONIC IMMUNE THROMBCYTOPENIC PURPURA.
Nouraei, S.A.R., Obholzer, R., Ind, P.W., Salama, A.D., Pusey, C.D., Porter, F., ...Sandhu, G.S. (2008). Results of endoscopic surgery and intralesional steroid therapy for airway compromise due to tracheobronchial Wegener's granulomatosis.
Nouraei, S.A.R., Obholzer, R., Ind, P.W., Salama, A.D., Pusey, C.D., Porter, F., ...Sandhu, G.S. (2008). Results of endoscopic surgery and intralesional steroid therapy for airway compromise due to tracheobronchial Wegener's granulomatosis.. THORAX, 63 (1), 49-52. doi:10.1136/thx.2007.078915
Pepper, R.J., Fabre, M.A., Pavesio, C., Gaskin, G., Jones, R.B., Jayne, D., ...Salama, A.D. (2008). Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production.. RHEUMATOLOGY, 47 (7), 1104-1105. doi:10.1093/rheumatology/ken175
Lachmann, N., El-Awar, N., Salama, A., Terasaki, P.I., Schoenemann, C. (2008). Single amino acid mismatches determine immunogenic HLA epitopes.
Lachmann, N., El-Awar, N., Deng, C., Cai, J., Salama, A., Terasaki, P.I., Schoenemann, C. (2008). Single amino acid mismatches provoke the development of polyspecific anti-HLA alloantibodies after first kidney transplantation: a case report.
Salama, A.D., Sayegh, M.H. (2008). Transplantation tolerance. In Brenner, B.M., Rector, F.C. (Eds.), Brenner and Rector's the kidney. W.B. Saunders Company.

2007

Salama, A., Pusey, C., Jayne, D., Mosley, K. (2007). ABAVAS: A trial of CTLA4Ig in ANCA vasculitis.
Salama, A.D. (2007). Chapter 6 Renal Toxicities Associated with Immunomodulatory Drugs. .
Salama, A.D., Womer, K.L., Sayegh, M.H. (2007). Clinical transplantation tolerance: many rivers to cross.. JOURNAL OF IMMUNOLOGY, 178 (9), 5419-5423. doi:10.4049/jimmunol.178.9.5419
Onions, L., Brookes, P., Mclean, A., Taube, D., Warrens, A., Dorling, A., Salama, A. (2007). Generation of regulatory T cells in renal transplant recipients following induction therapy with Campath-1H and Daclizumab.
Salama, A.D. (2007). How high is the risk of ANCA-associated vasculitis recurring after renal transplantation?. NATURE CLINICAL PRACTICE NEPHROLOGY, 3 (10), 538-539. doi:10.1038/ncpneph0585
Salama, A., Ryba, M., Levy, J., Gaskin, G., Pusey, C. (2007). Long-term outcome of patients with severe ANCA associated vasculitis treated with plasmapheresis.
Reynolds, J., Marsh, O.B., Sando, G.S., Salama, A.D., Pusey, C.D. (2007). Manipulation of the PD1/PDL1 negative T cell costimulatory pathway in treatment of established experimental autoimmune glomerulonephritis.
Taylor, S.R.J., Salama, A.D., Pusey, C.D., Lightman, S. (2007). Ocular manifestations of Wegener's granulomatosis. Expert Review of Ophthalmology, 2 (1), 91-103. doi:10.1586/17469899.2.1.91
Salama, A.D. (2007). Pediatric solid organ transplantation. In Fine, R.N. (Ed.), Pediatric solid organ transplantation. Wiley-Blackwell.
Salama, A.D. (2007). Renal biopsy. Medicine, 35 (7), 383-385. doi:10.1016/j.mpmed.2007.04.007
Salama, A.D. (2007). The kidney in systemic autoimmune diseases Renal Toxicities associated with immunomodulatory drugs. In Mason, J.C., Pusey, C.D. (Eds.), The kidney in systemic autoimmune diseases. Elsevier Science.
Reynolds, J., Maine, C., Sando, G.S., Salama, A.D., Pusey, C.D. (2007). Transfer of tolerance to naive recipients by CD4+ and CD25+ T cells from donors with experimental autoimmune glomerulonephritis treated with an anti-ICOSL monoclonal antibody.
Summers, S.A., Salama, A.D., Cook, T., Clarke, H., Dorling, A. (2007). TRANSPLANT ACCOMMODATION IS ASSOCIATED WITH LONG TERM RENAL ALLOGRAFT SURVIVAL AFTER TRANSPLANTATION INTO HIGHLY SENSITISED RECIPIENTS.

2006

Salama, A.D., Pusey, C.D. (2006). Drug insight: rituximab in renal disease and transplantation.. NATURE CLINICAL PRACTICE NEPHROLOGY, 2 (4), 221-230. doi:10.1038/ncpneph0133
Hernandez-Fuentes, M.P., Salama, A. (2006). In vitro assays for immune monitoring in transplantation.. Methods in molecular biology (Clifton, N.J.), 333 269-290. doi:10.1385/1-59745-049-9:269

2005

Yamada, A., Salama, A.D., Sho, M., Najafian, N., Ito, T., Forman, J.P., ...Clarkson, M.R. (2005). CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo.. JOURNAL OF IMMUNOLOGY, 174 (3), 1357-1364. doi:10.4049/jimmunol.174.3.1357
Sandner, S.E., Clarkson, M.R., Salama, A.D., Sanchez-Fueyo, A., Yagita, H., Turka, L.A., Sayegh, M.H. (2005). Mechanisms of tolerance induced by donor-specific transfusion and ICOS-B7h blockade in a model of CD4+ T-cell-mediated allograft rejection.. AMERICAN JOURNAL OF TRANSPLANTATION, 5 (1), 31-39. doi:10.1111/j.1600-6143.2004.00640.x
Salama, A.D., Sayegh, M.H. (2005). Medical management of kidney transplantation. In Weir, M.R. (Ed.), Medical management of kidney transplantation. .
Patel, A., Ind, P., Pusey, C.D., Gaskin, G., Salama, A. (2005). Outcomes of pulmonary renal syndrome in patients with ANCA associated vasculitis.
Sandner, S.E., Clarkson, M.R., Salama, A.D., Sanchez-Fueyo, A., Domenig, C., Habicht, A., ...Turka, L.A. (2005). Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo.. JOURNAL OF IMMUNOLOGY, 174 (6), 3408-3415. doi:10.4049/jimmunol.174.6.3408
Salama, A.D. (2005). Tipping the balance in glomerulonephritis. J AM SOC NEPHROL, 16 (5), 1169-1171. doi:10.1061/ASN.2005030304
Salama, A.D. (2005). Tipping the balance in glomerulonephritis.. Journal of the American Society of Nephrology, 16 (5), 1169-1171. doi:10.1681/ASN.2005030304

2004

Chitnis, T., Salama, A.D., Grusby, M.J., Sayegh, M.H., Khoury, S.J. (2004). Defining Th1 and Th2 immune responses in a reciprocal cytokine environment in vivo.. JOURNAL OF IMMUNOLOGY, 172 (7), 4260-4265. doi:10.4049/jimmunol.172.7.4260
Salama, A.D. (2004). Disease models of rapidly progressive glomerulonephritis. Drug Discovery Today: Disease Models, 1 (4), 457-463. doi:10.1016/j.ddmod.2004.11.002
Izawa, A., Clarkson, M.R., Salama, A.D., Ueno, T., Yagita, H., Sharpe, A.H., ...Najafian, N. (2004). Generation of regulatory CD8(+) T cells by ICOS-B7h signal blockade in vivo..
Reyal, Y., Robinson, C., Salama, A., Levy, J.B. (2004). Neurological complications from brachial arteriovenous fistulae.. NEPHROLOGY DIALYSIS TRANSPLANTATION, 19 (7), 1923-1924. doi:10.1093/ndt/gfh290
Clarkson, M.R., Salama, A.D., Mueller, T., Fernandes, S., Harmon, W.E., Sayegh, M.H., Najafian, N. (2004). Regulatory phenotype is enriched in the CD25 'high' sub-population of CD4(+)CD25(+) cells expanded from renal transplant recipients..
Yuan, X.L., Clarkson, M.R., Schmitt, I., Salama, A.D., Auchincloss, H., Glimcher, L.H., Sayegh, M.H. (2004). T-bet deficient recipients exhibit a Th2 phenotype, develop accelerated acute and chronic humoral vascularized allograft rejection, and are resistant to immunosuppression and tolerance..

2003

Salama, A.D., Sayegh, M.H. (2003). Alternative T-cell costimulatory pathways in transplant rejection and tolerance induction: hierarchy or redundancy?. AMERICAN JOURNAL OF TRANSPLANTATION, 3 (5), 509-511. doi:10.1034/j.1600-6143.2003.00114.x
Pusey, C.D., Harrington, J.T., Dasgupta, I., Feehally, J., Rees, A., Hughes, J., ...Winearls, C. (2003). Anti-glomerular basement membrane disease. KIDNEY INTERNATIONAL, 64 (4), 1535-1550. doi:10.1046/j.1523-1755.2003.00241.x
Salama, A.D., Yamada, A., Forman, J., Kewalramani, R., Najafian, N., Ito, T., ...Mandelbrot, D. (2003). CD70-CD27 is a critical CD28-independent costimulatory pathway for alloimmune CD8+T cell responses.
Salama, A.D., Chitnis, T., Imitola, J., Ansari, M.J.I., Akiba, H., Tushima, F., ...Khoury, S.J. (2003). Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis (vol 198, pg 71, 2003). J EXP MED, 198 (4), 677.
Salama, A.D., Chitnis, T., Imitola, J., Ansari, M.J.I., Akiba, H., Tushima, F., ...Khoury, S.J. (2003). Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis.. JOURNAL OF EXPERIMENTAL MEDICINE, 198 (1), 71-78. doi:10.1084/jem.20022119
Salama, A.D., Chitnis, T., Imitola, J., Ansari, M.J.I., Akiba, H., Tushima, F., ...Khoury, S.J. (2003). Erratum: (The Journal of Experimemal Medicine (July 7, 2003) 198:1 (71-78)). Journal of Experimental Medicine, 198 (4), 677-. doi:10.1084/jem.2003071719871corr
Clarkson, M.R., Salama, A.D., Mueller, T., Sayegh, M.H., Najafian, N. (2003). Expansion and characterization of CD4(+)CD25(+) regulatory T-cells from human renal transplant recipients..
Najafian, N., Sandner, S.E., Ito, T., Kewalramani, R., Salama, A.D., Yagita, H., ...Sayegh, M.H. (2003). Functions of the PD-1: PD-L1 costimulatory pathway in physiologic regulation of alloimmune responses in vivo.
Salama, A.D., Yuan, X., Nayer, A., Chandraker, A., Inobe, M., Uede, T., Sayegh, M.H. (2003). Interaction between ICOS-B7RP1 and B7-CD28 costimulatory pathways in alloimmune responses in vivo.. AMERICAN JOURNAL OF TRANSPLANTATION, 3 (4), 390-395. doi:10.1034/j.1600-6143.2003.00085.x
Sandner, S.E., Salama, A.D., Houser, S.L., Palmer, E., Turka, L.A., Sayegh, M.H. (2003). New TCR transgenic model for tracking allospecific CD4 T-cell activation and tolerance in vivo.. AMERICAN JOURNAL OF TRANSPLANTATION, 3 (10), 1242-1250. doi:10.1046/j.1600-6143.2003.00220.x
Salama, A.D., Chaudhry, A.N., Holthaus, K.A., Mosley, K., Kalluri, R., Sayegh, M.H., ...Lightstone, L. (2003). Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture's (anti-GBM) disease.. KIDNEY INTERNATIONAL, 64 (5), 1685-1694. doi:10.1046/j.1523-1755.2003.00259.x
Salama, A.D., Najafian, N., Clarkson, M.R., Harmon, W.E., Sayegh, M.H. (2003). Regulatory CD25+ T cells in human kidney transplant recipients.. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 14 (6), 1643-1651. doi:10.1097/01.ASN.0000057540.98231.C1
Najafian, N., Chitnis, T., Salama, A.D., Zhu, B., Benou, C., Yuan, X.L., ...Khoury, S.J. (2003). Regulatory functions of CD8(+)CD28(-) T cells in an autoimmune disease model. JOURNAL OF CLINICAL INVESTIGATION, 112 (7), 1037-1048. doi:10.1172/JCI200317935
Najafian, N., Chitnis, T., Salama, A.D., Zhu, B., Benou, C., Yuan, X., ...Khoury, S.J. (2003). Regulatory functions of CD8+CD28- T cells in an autoimmune disease model.. Journal of Clinical Investigation, 112 (7), 1037-1048. doi:10.1172/JCI17935
Ansari, M.J.I., Salama, A.D., Chitnis, T., Smith, R.N., Yagita, H., Akiba, H., ...Khoury, S.J. (2003). The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice.. JOURNAL OF EXPERIMENTAL MEDICINE, 198 (1), 63-69. doi:10.1084/jem.20022125
Forman, J.P., Latchman, Y.E., Salama, A.D., Blazar, B.R., Sharpe, A.H., Sayegh, M.H. (2003). The role of B7 and CD2 family costimulatory molecules in natural killer cell function.
Yuan, X., Salama, A.D., Dong, V., Schmitt, I., Najafian, N., Chandraker, A., ...Sayegh, M.H. (2003). The role of the CD134-CD134 ligand costimulatory pathway in alloimmune responses in vivo.. JOURNAL OF IMMUNOLOGY, 170 (6), 2949-2955. doi:10.4049/jimmunol.170.6.2949
Harada, H., Salama, A.D., Sho, M., Izawa, A., Sandner, S.E., Ito, T., ...Freeman, G.J. (2003). The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity. JOURNAL OF CLINICAL INVESTIGATION, 112 (2), 234-243. doi:10.1172/JCI200317008
Harada, H., Salama, A.D., Sho, M., Izawa, A., Sandner, S.E., Ito, T., ...Freeman, G.J. (2003). The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity.. Journal of Clinical Investigation, 112 (2), 234-243. doi:10.1172/JCI200317008
Yuan, X.L., Clarkson, M.R., Schmitt, I., Salama, A.D., Auchincloss, H., Glimcher, L.H., Sayegh, M.H. (2003). The role of the novel gene, T-bet, in allograft rejection and tolerance..
Salama, A.D., Levy, J.B. (2003). Tolerance and autoimmunity in anti-GBM disease.. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 14 (11), 2988-2989. doi:10.1097/01.ASN.0000096785.86791.68

2002

Yuan, X., Dong, V.M., Coito, A.J., Waaga, A.-.M., Salama, A.D., Benjamin, C.D., ...Chandraker, A. (2002). A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.. TRANSPLANTATION, 73 (11), 1736-1742. doi:10.1097/00007890-200206150-00008
Sayegh, M.H., Sandner, S., Salama, A., Langmuir, P., Palmer, E., Turka, L.A. (2002). A novel transgenic model for tracking alloreactive CD4+T cell responses and investigating the mechanisms of tolerance in vivo..
Salama, A.D. (2002). Acute renal failure in practice. In Glynne, P., Allen, A., Pusey, C. (Eds.), Acute renal failure in practice. Imperial College Pr.
Chitnis, T., Benou, C., Najafian, N., Salama, A.D., Grusby, M.J., Sayegh, M.H., Khoury, S.J. (2002). Blockade of T-cell costimulatory pathways protects from experimental autoimmune encephalomyelitis in Th2 deficient mice.
Salama, A.D., Sayegh, M.H. (2002). Challenges for the translation of T cell costimulatory blockade therapies to the clinic.. EXPERT OPINION ON BIOLOGICAL THERAPY, 2 (5), 453-457.
Dougan, T., Levy, J.B., Salama, A., George, A.J.T., Pusey, C.D. (2002). Characterization of autoantibodies from patients with Goodpasture's disease using a resonant mirror biosensor.. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 128 (3), 555-561. doi:10.1046/j.1365-2249.2002.01867.x
Yuan, X., Dong, V.M., Coito, A.J., Waaga, A., Salama, A.D., Benjamin, C.D., ...Chandraker, A. (2002). Effects of CD40/CD154 blockade on allograft rejection.
Najafian, N., Salama, A.D., Fedoseyeva, E.V., Benichou, G., Sayegh, M.H. (2002). Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients.. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 13 (1), 252-259.
Salama, A.D., Dougan, T., Levy, J.B., Cook, H.T., Morgan, S.H., Naudeer, S., ...Lightstone, L. (2002). Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques.. AMERICAN JOURNAL OF KIDNEY DISEASES, 39 (6), 1162-1167. doi:10.1053/ajkd.2002.33385
Salama, A.D., Pusey, C.D. (2002). Immunology of anti-glomerular basement membrane. CURR OPIN NEPHROL HY, 11 (3), 279-286.
Salama, A.D., Pusey, C.D. (2002). Immunology of anti-glomerular basement membrane disease.. Current Opinion in Nephrology and Hypertension, 11 (3), 279-286. doi:10.1097/00041552-200205000-00003
Salama, A.D., Yuan, X.L., Uede, T., Chandraker, A., Sayegh, M.H. (2002). Interactions between the ICOS-B7H and the CD28-B7 costimulatory pathways in regulating alloimmune responses in vivo..
Sho, M., Sandner, S.E., Najafian, N., Salama, A.D., Dong, V., Yamada, A., ...Sayegh, M.H. (2002). New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs.. ANNALS OF SURGERY, 236 (5), 667-675. doi:10.1097/00000658-200211000-00018
Sho, M., Yamada, A., Najafian, N., Salama, A.D., Harada, H., Sandner, S.E., ...Sayegh, M.H. (2002). Physiological mechanisms of regulating alloimmunity: cytokines, CTLA-4, CD25+ cells, and the alloreactive T cell clone size.. JOURNAL OF IMMUNOLOGY, 169 (7), 3744-3751. doi:10.4049/jimmunol.169.7.3744
Ansari, M.J.I., Salama, A.D., Auchincloss, H., Sayegh, M.H. (2002). Regulation of autoimmune diabetes in NOD mice: Critical role for the PD-1 : PD-L1 costimulatory pathway..
Zhai, Y., Shen, X.-.D., Gao, F., Coito, A.J., Wasowska, B.A., Salama, A., ...Kupiec-Weglinski, J.W. (2002). The CD154-CD40 T cell costimulation pathway is required for host sensitization of CD8(+) T cells by skin grafts via direct antigen presentation.. JOURNAL OF IMMUNOLOGY, 169 (3), 1270-1276. doi:10.4049/jimmunol.169.3.1270
Salama, A.D., Chaudhry, A., Sayegh, M.H., Lechler, R.I., Pusey, C.D., Lightstone, L. (2002). The role of CD25+regulatory cells in restoring tolerance in autoimmune anti-GBM (Goodpasture's) disease..
Najafian, N., Salama, A.D., Harmon, W.E., Sayegh, M.H. (2002). The role of CD25+regulatory T cells as modulators of the indirect alloimmune response in stable human renal transplant recipients..
Yamada, A., Salama, A.D., Sayegh, M.H. (2002). The role of novel T cell costimulatory pathways in autoimmunity and transplantation.. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 13 (2), 559-575.

2001

Salama, A.D., Sayegh, M.H. (2001). Achieving clinical transplant tolerance: What are the hurdles?.
Yamada, A., Kishimoto, K., Dong, V.M., Sho, M., Salama, A.D., Anosova, N.G., ...Turka, L.A. (2001). CD28-independent costimulation of T cells in alloimmune responses.. JOURNAL OF IMMUNOLOGY, 167 (1), 140-146. doi:10.4049/jimmunol.167.1.140
Salama, A.D., Remuzzi, G., Harmon, W.E., Sayegh, M.H. (2001). Challenges to achieving clinical transplantation tolerance.. JOURNAL OF CLINICAL INVESTIGATION, 108 (7), 943-948. doi:10.1172/JCI200114142
Chitnis, T., Najafian, N., Benou, C., Salama, A.D., Grusby, M.J., Sayegh, M.H., Khoury, S.J. (2001). Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis.. JOURNAL OF CLINICAL INVESTIGATION, 108 (5), 739-747. doi:10.1172/JCI12563
Salama, A.D. (2001). Erratum: Goodpasture's disease (The Lancet (Sept. 15) (917)). Lancet, 358 (9290), 1374-.
Salama, A.D., Levy, J.B., Lightstone, L., Pusey, C.D. (2001). Goodpasture's disease.. LANCET, 358 (9285), 917-920. doi:10.1016/S0140-6736(01)06077-9
Salama, A.D., Chaudhry, A.N., Ryan, J.J., Eren, E., Levy, J.B., Pusey, C.D., ...Lechler, R.I. (2001). In Goodpasture's disease, CD4(+) T cells escape thymic deletion and are reactive with the autoantigen alpha3(IV)NC1.. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 12 (9), 1908-1915.
Sho, M., Salama, A.D., Yamada, A., Najafian, N., Sayegh, M.H. (2001). Physiologic regulation of alloimmune responses in vivo: the role of CTLA4 and TH1/TH2 cytokines.. TRANSPLANTATION PROCEEDINGS, 33 (7-8), 3826-3828. doi:10.1016/S0041-1345(01)02620-3
Salama, A.D., Pusey, C.D. (2001). Rheumatology and the kidney Tubulointerstitial nephritis. In Adu, D., Emery, P., Madaio, M.P. (Eds.), Rheumatology and the kidney. Oxford University Press, USA.
Yamada, A., Salama, A.D., Najafian, N., Auchincloss, H., Sayegh, M.H. (2001). TNF:TNF-R T-Cell costimulatory pathways in transplantation.. TRANSPLANTATION PROCEEDINGS, 33 (7-8), 3070-3071. doi:10.1016/S0041-1345(01)02309-0
Salama, A.D., Delikouras, A., Pusey, C.D., Cook, H.T., Bhangal, G., Lechler, R.I., Dorling, A. (2001). Transplant accommodation in highly sensitized patients: a potential role for Bcl-xL and alloantibody.. AMERICAN JOURNAL OF TRANSPLANTATION, 1 (3), 260-269. doi:10.1034/j.1600-6143.2001.001003260.x

1999

Baker, R.J., Salama, A.D., Chaudhry, A.N., Cook, H.T., Pusey, C.D. (1999). Acute tubulointerstitial nephritis - a clinicopathological study of 22 patients..
Warrens, A.N., Waters, J.B., Salama, A.D., Lechler, R.I. (1999). Improving the therapeutic monitoring of cyclosporin A.. CLINICAL TRANSPLANTATION, 13 (2), 193-200. doi:10.1034/j.1399-0012.1999.130207.x
Salama, A.D. (1999). Pathogenesis and treatment of ANCA-associated systemic vasculitis.. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 92 (9), 456-461. doi:10.1177/014107689909200906
Glynne, P., Salama, A., Chaudhry, A., Swirsky, D., Lightstone, L. (1999). Quinine-induced immune thrombocytopenic purpura followed by hemolytic uremic syndrome.. AMERICAN JOURNAL OF KIDNEY DISEASES, 33 (1), 133-137. doi:10.1016/S0272-6386(99)70269-6
Salama, A., Dorling, A., Hayes, M., Bhangal, G., Delikouras, A., Malde, P., ...Lechler, R. (1999). Transplant accommodation is associated with up-regulation or anti-apoptotic proteins: In vitro models implicate iNOS induction by low levels or anti-donor antibody in accommodated endothelial cells.

1998

Salama, A.D., Pusey, C.D. (1998). Images in clinical medicine. Tuberous sclerosis.. New England Journal of Medicine, 338 (26 I), 1886-. doi:10.1056/NEJM199806253382605
Salama, A. (1998). Treatment of renal angiomyolipoma - Reply. NEW ENGLAND JOURNAL OF MEDICINE, 339 (19), 1400.
Salama, A.D., Pusey, C.D. (1998). Tuberous sclerosis. NEW ENGL J MED, 338 (26), 1886.

1997

Salama, A.D., Rogers, T., Lord, G.M., Lechler, R.I., Mason, P.D. (1997). Multiple Cladosporium brain abscesses in a renal transplant patient: aggressive management improves outcome.. TRANSPLANTATION, 63 (1), 160-162. doi:10.1097/00007890-199701150-00030
Lightstone, L., Glynne, P., Salama, A. (1997). Quinine-dependent anti-glycoprotein antibodies causing thrombocytopenia and hemolytic uremic syndrome (HUS)..
Lightstone, L., Salama, A., Malik, A., Fullwood, Y. (1997). Resident renal cell populations may be able to function as antigen presenting cells to CD4+ T cells..

1996

Warrens, A.N., Salama, A., Waters, J.B., Lechler, R.I. (1996). Comparison of Neoral and Sandimmune preparations in renal transplant patients--improved pharmacokinetics with neoral.. TRANSPLANTATION PROCEEDINGS, 28 (4), 2169-2170.

1900

Salama, A.D., Henderson, S.R. (1900). Haemorrhage and thrombosis: tackling two sides of a single vasculitic disease.. Nephrology Dialysis Transplantation, 2012 Aug 16 EPub
Henderson, S., Copley, S., Pusey, C.D., Ind, P.W., Salama, A.D. (1900). Prolonged B Cell Depletion with Rituximab is Effective in Treating Refractory Pulmonary Granulomatous Inflammation in Granulomatosis with Polyangiitis. Medicine,
Derrett-Smith, E.C. (1900). Revisiting ANCA-associated vasculitis in systemic sclerosis: clinical, serological and immunogenetic factors. Rheumatology, doi:10.1093/rheumatology/ket213
Pepper, R.J., Wang, H.H., Rajakaruna, G.K., Papakrivopoulou, E., Vogl, T., Pusey, C.D., ...Salama, A.D. (1900). S100A8/A9 (calprotectin) is critical for development of glomerulonephritis promoting inflammatory leukocyte-renal cell interactions. American Journal of Pathology,